Asia Healthcare Holdings takes majority stake in Asian Institute of Nephrology and Urology
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
The hospital hosted a two-day event with top internal and external faculty and medical experts
This indigenously developed enhanced care technology is designed to continuously monitor and detect early signs of deterioration in a patient's condition
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
Jemperli is the only immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy
The programme was conducted as a part of MPMCx, an exclusive management programme for MBBS doctors by IIM-Ahmedabad in collaboration with DailyRounds
Investment enables development of revolutionary multi-omic platform using super-resolution imaging technology for earlier disease detection and accelerated discovery of therapeutics
Subscribe To Our Newsletter & Stay Updated